Longeveron
PublicLongeveron is now publicly traded
The data on this page reflects Longeveron's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Mar 11, 2026
Total Funding Raised
$36.45M
Company Overview
Longeveron operates in Healthcare and is based in the United States. It has raised $36.45M.
Longeveron is a clinical-stage biotechnology company that develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan.
Sector
Healthcare
AI Layer
Non-AI
Longeveron Comparables
Compare Longeveron with similar companies based on industry and business-model similarity.
No comparables are published for Longeveron. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Longeveron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 11, 2026 | ||||
| Private Placement | Dec 3, 2021 | ||||
| Private Placement | Jan 22, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Longeveron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Private Placement |
| Coastlands Capital LP | Private Placement |
| Kalehua Capital Management | Private Placement |
| Logos Capital | Private Placement |
Longeveron Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.